Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;29(4):416-20.
doi: 10.1038/modpathol.2016.29. Epub 2016 Feb 12.

Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians

Affiliations

Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians

Christopher P Larsen et al. Mod Pathol. 2016 Apr.

Abstract

Large case series of renal amyloidosis subtypes have recently been published in the United States and Europe showing AL amyloidosis to be the predominant subtype in this part of the world. However, the most common subtypes of renal amyloidosis throughout the rest of the world are unknown. We present here the first large case series detailing the subtypes of renal amyloidosis among Egyptians. In this population, AA amyloidosis was the most common type of amyloidosis on renal biopsy at 48%. The newly described leukocyte chemotactic factor 2 amyloidosis (ALECT2) was the second most common type and represented nearly one-third of renal amyloid cases at 31%. AL accounted for only 20% of cases. The pathologic findings in ALECT2 cases were similar to those previously described in other case series. Thus ALECT2, which was initially thought to affect mainly Hispanics in the United States, appears to represent an important and likely underrecognized etiology of chronic kidney disease among Egyptians and probably in other ethnic groups around the world.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Laser microdissection/mass spectrometry in a patient with renal ALECT2 amyloidosis. (a-c) Renal parenchymal congophilic amyloid deposits from a patient with ALECT2 are visualized under fluorescent light and marked for microdissection. Three separate microdissections (LMD#1, LMD#2, and LMD#3) are analyzed. (d) Scaffold software display of amyloid-associated proteins identified within the deposits by liquid chromatography/tandem mass spectrometry. The three columns on the right represent the separate micro-dissected samples run in triplicate. The numbers within the columns represent the total number of mass spectra corresponding to the identified protein and the color of the box reflects the probability that the spectra are correctly assigned to the identified protein (all >95%). In this case, the presence of abundant spectra for serum amyloid P and apolipoprotein E is indicative of amyloid, whereas the presence of abundant spectra for leukocyte cell-derived chemotaxin 2 (LECT2) establishes the identity of the amyloid as ALECT2.
Figure 2
Figure 2
Leukocyte chemotactic factor 2 amyloidosis. (a and b) Uptake of Congo red by glomerular and interstitial amyloid deposits (a) with green birefringence upon (b) polarization (original magnification × 200). (c) Extensive amorphous deposits of LECT2 amyloid in the glomeruli and interstitial compartments (hematoxylin and eosin; original magnification × 200). (d) Reactivity of glomerular and interstitial amyloid deposits with an anti-LECT2 antibody (immunoperoxidase technique, × 200).

References

    1. Sipe JD, Benson MD, Buxbaum JN et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 2014;21:221–224. - PubMed
    1. Nasr SH, Dogan A, Larsen CP. Leukocyte cell–derived chemotaxin 2–associated amyloidosis: A recently recognized disease with distinct clinicopathologic characteristics. Clin J Am Soc Nephrol 2015;10:2084–2093. - PMC - PubMed
    1. Benson MD, James S, Scott K et al. Leukocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int 2008;74:218–222. - PubMed
    1. Larsen CP, Walker PD, Weiss DT et al. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int 2010;77:816–819. - PMC - PubMed
    1. Hutton HL, DeMarco ML, Magil AB et al. Renal leukocyte chemotactic factor 2 (LECT2) amyloidosis in first nations people in northern British Columbia, Canada: a report of 4 cases. Am J Kidney Dis 2014;64:790–792. - PubMed

Substances